Press Releases LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Market Closed - OTC Markets Other stock markets 03:36:11 2024-07-10 pm EDT			5-day change	1st Jan Change
0.0169 ^USD	+28.22%		+14.19%	-73.13%

May. 24	Roche, LumiraDx Deal Probed by U.K. Competition Watchdog	DJ
May. 20	U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx	DJ

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	Jan. 08	AQ
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	Jan. 05	GL
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	Jan. 02	AQ
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	Dec. 29	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	Dec. 29	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	Dec. 11	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	Nov. 21	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	Nov. 06	PU
LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal	23-10-27	GL
Catheter Precision Inc. (NYSEAMERICAN: VTAK) Revolutionizing Heart Health, VTAK, LMDX, AKU, INPX, AZN	23-10-27	AQ
BigTime Penny Stocks: Low-Priced Small-Cap Stocks (IVP, LMDX, GROM, GCTK, UFAB)	23-10-23	AQ
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub	23-10-20	AQ
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub	23-10-20	GL
LumiraDx : INDEX TO FINANCIAL STATEMENTS - Form 6-K	23-10-03	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	23-09-18	PU
LumiraDx Reports Second Quarter 2023 Results	23-08-24	GL
LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24	23-08-16	GL
CapitalGainsReport Potential Breakouts Watchlist (SHGI, IQST, PHUN LMDX)	23-08-01	AQ
LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests	23-07-31	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	23-07-21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Press Releases

Filters